ZBTB16, also named as PLZF, has previously been shown to be down-regulated in hepatocellular carcinoma, which supports our current study that ZBTB16 was down-regulated in liver cancer specimens compared to non-tumor liver specimens (Hui et al., 2015). Here, ZBTB16 is linked to liver cancer.